60 Degrees Pharmaceuticals, Inc. - Common Stock (SXTP)
0.5290
+0.0173 (3.38%)
60 Degrees Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing innovative treatments to address unmet medical needs
The company is particularly dedicated to creating novel therapeutics for infectious diseases, with an emphasis on leveraging advanced drug delivery systems to improve patient outcomes and enhance the efficacy of existing treatment paradigms. By conducting research and clinical trials, 60 Degrees Pharmaceuticals aims to bring transformative therapies to market that can significantly alter the course of disease treatment and management for patients worldwide.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
After the conclusion of the US market's regular session on Tuesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
ORLANDO, FL / ACCESSWIRE / December 2, 2024 / RedChip Companies aired interviews with VSee Health, Inc. (Nasdaq:VSEE) and 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV on November 30. Bloomberg TV is available in an estimated 73 million homes across the U.S.
ORLANDO, FL / ACCESSWIRE / November 22, 2024 / RedChip Companies will air interviews with 60 Degrees Pharmaceuticals, Inc. (Nasdaq:SXTP) and Can-Fite BioPharma Ltd. (NYSE American:CANF)(TASE:CANF) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, November 23, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
60 Degrees Pharmaceuticals Inc. (NASDAQSXTP) shares are surging on Friday following the company's announcement of clinical trial agreements for their Tafenoquine Babesiosis study.
